Stock Price
258.74
Daily Change
-1.27 -0.49%
Monthly
-0.56%
Yearly
-17.35%
Q1 Forecast
263.64

Cochlear reported AUD17.01B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 2.91B 2.03B Jun/2025
Avita Medical AUD 140.79M 194.8M Jun/2025
Cochlear AUD 19.65B 679.76M Jun/2025
CSL USD 76.3B 60.04B Jun/2025
Fisher Paykel Healthcare NZD 22.81B 1.05B Feb/2026
Healius AUD 570.01M 424.79M Jun/2025
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Mayne Pharma AUD 406.23M 2.44M Jun/2025
Mesoblast USD 1.39B 2.16B Jun/2025
Monash IVF AUD 274.69M 220.14M Jun/2025
Nanosonics AUD 1.23B 316.03M Jun/2025
Polynovo AUD 825.56M 583.76M Jun/2025
Regis Healthcare AUD 1.81B 494.98M Dec/2024
ResMed USD 39.31B 13.21B Feb/2026
Sigma Healthcare AUD 3.05B 1.63B Jan/2026
Sonic Healthcare AUD 12.87B 105.69M Jun/2025
Telix Pharmaceuticals AUD 10.88B 2.64B Jun/2025